Simposi


Pharmacological control of tumor necrosis factor (TNF) in immunomediated inflammatory diseases (IMID): the value of Adalimumab

Thursday, October 26th / 14.00-15.00
123 Adalimumab value in adult IMID
Ennio Giulio Favalli
124 Adalimumab value in child IMID
Anna Belloni Fortina
170 Pharmacological modulation of TNF in IMID: quality and safety profile
Corrado Blandizzi